EGFR and non-small cell lung carcinoma: Epidemiological studies investigated the difference in clinical characteristics between EGFR mutant and EGFR wild-type NSCLC patients, which showed that EGFR mutations were significantly associated with female, never-smokers and lung ADC [6–9].